{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T04:24:35Z","timestamp":1743049475859,"version":"3.40.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"DOI":"10.7759\/cureus.81250","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:19:59Z","timestamp":1743031199000},"source":"Crossref","is-referenced-by-count":0,"title":["Central Nervous System Involvement in Splenic Marginal Zone Lymphoma"],"prefix":"10.7759","author":[{"given":"Kabeer","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Miatech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falguni","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Karan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter JR","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.09.012","article-title":"Extranodal marginal zone lymphoma of the central nervous system","volume":"18","author":"Ayanambakkam A","year":"2018","unstructured":"Ayanambakkam A, Ibrahimi S, Bilal K, Cherry MA. Extranodal marginal zone lymphoma of the central nervous system. Clin Lymphoma Myeloma Leuk. 2018, 18:34-37.e8. 10.1016\/j.clml.2017.09.012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12730","article-title":"Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site","volume":"165","author":"Khalil MO","year":"2014","unstructured":"Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014, 165:67-77. 10.1111\/bjh.12730","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2016.07.002","article-title":"Epidemiology and environmental aspects of marginal zone lymphomas","volume":"30","author":"Sriskandarajah P","year":"2017","unstructured":"Sriskandarajah P, Dearden CE. Epidemiology and environmental aspects of marginal zone lymphomas. Best Pract Res Clin Haematol. 2017, 30:84-91. 10.1016\/j.beha.2016.07.002","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0976-3","article-title":"Central nervous system manifestations of marginal zone B-cell lymphoma","volume":"89","author":"Bayraktar S","year":"2010","unstructured":"Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol. 2010, 89:1003-9. 10.1007\/s00277-010-0976-3","journal-title":"Ann Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa032","article-title":"Extranodal marginal zone lymphoma of the central nervous system includes parenchymal-based cases With characteristic features","volume":"154","author":"Nomani L","year":"2020","unstructured":"Nomani L, Cotta CV, Hsi ED, Ferry JA, Cook JR. Extranodal marginal zone lymphoma of the central nervous system includes parenchymal-based cases With characteristic features. Am J Clin Pathol. 2020, 154:124-32. 10.1093\/ajcp\/aqaa032","journal-title":"Am J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/his.12706","article-title":"Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart","volume":"67","author":"Chang C","year":"2015","unstructured":"Chang C, Lin CH, Cheng AL, Medeiros LJ, Chang KC. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart. Histopathology. 2015, 67:625-35. 10.1111\/his.12706","journal-title":"Histopathology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5414\/NP300579","article-title":"Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the central nervous system (MZL CNS) presented as traumatic subdural hematoma and subarachnoid bleeding - case report","volume":"32","author":"Jesionek-Kupnicka D","year":"2013","unstructured":"Jesionek-Kupnicka D, Smolewski P, Kupnicki P, Pluciennik E, Zawlik I, Papierz W, Kordek R. Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the central nervous system (MZL CNS) presented as traumatic subdural hematoma and subarachnoid bleeding - case report. Clin Neuropathol. 2013, 32:384-92. 10.5414\/NP300579","journal-title":"Clin Neuropathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00267","article-title":"A rare case of composite dural extranodal marginal zone lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"9","author":"Bustoros M","year":"2018","unstructured":"Bustoros M, Liechty B, Zagzag D, et al.. A rare case of composite dural extranodal marginal zone lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma. Front Neurol. 2018, 9:267. 10.3389\/fneur.2018.00267","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1218006","article-title":"Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences","volume":"58","author":"de la Fuente MI","year":"2017","unstructured":"de la Fuente MI, Haggiagi A, Moul A, et al.. Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leuk Lymphoma. 2017, 58:882-8. 10.1080\/10428194.2016.1218006","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-321349","article-title":"How I treat primary CNS lymphoma","volume":"118","author":"Ferreri AJ","year":"2011","unstructured":"Ferreri AJ. How I treat primary CNS lymphoma. Blood. 2011, 118:510-22. 10.1182\/blood-2011-03-321349","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003097","article-title":"Primary marginal zone lymphoma of the cns presenting as a diffuse leptomeningeal process","volume":"87","author":"Gazzola DM","year":"2016","unstructured":"Gazzola DM, Arbini AA, Haglof K, Pacia SV. Primary marginal zone lymphoma of the cns presenting as a diffuse leptomeningeal process. Neurology. 2016, 87:1180-2. 10.1212\/WNL.0000000000003097","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13994","article-title":"Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B\u2011cell lymphoma: A case report","volume":"26","author":"Fiorentino V","year":"2023","unstructured":"Fiorentino V, Pizzimenti C, Pierconti F, et al.. Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B\u2011cell lymphoma: A case report. Oncol Lett. 2023, 26:408. 10.3892\/ol.2023.13994","journal-title":"Oncol Lett"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0001","article-title":"Waldenstr\u00f6m Macroglobulinemia\/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Kumar SK","year":"2024","unstructured":"Kumar SK, Callander NS, Adekola K, et al.. Waldenstr\u00f6m Macroglobulinemia\/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024, 22:e240001. 10.6004\/jnccn.2024.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18368","article-title":"A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma","volume":"199","author":"Strati P","year":"2022","unstructured":"Strati P, Coleman M, Champion R, et al.. A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma. Br J Haematol. 2022, 199:76-85. 10.1111\/bjh.18368","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348611-central-nervous-system-involvement-in-splenic-marginal-zone-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T23:20:00Z","timestamp":1743031200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348611-central-nervous-system-involvement-in-splenic-marginal-zone-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.81250","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}